Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Labs Get Extra Year To Adjust To Diagnostics Reimbursement Revamp

This article was originally published in The Gray Sheet

Executive Summary

CMS issued a long-awaited final rule that will establish a new market-based approach to setting lab-test payment rates. The Medicare agency was convinced to delay implementation by one year, to 2018, and to make other tweaks to its policy that industry stakeholders say will make the system more accurate.


Related Content

Labs Have Two More Months To Report Private-Payer Data, CMS Says
CMS Administrator Seema Verma: What Industry Can Expect
Senate Committee Signals Approval Of Seema Verma To Run CMS, But Most Dems Will Vote 'No'
Recalled Device Costs, Test Payments Focus In OIG Work Plan
'Moonshot' Opportunities: Dx Reimbursement, Radiation Therapy Among Medtech Focal Points
CMS Takes Steps To Implement New Dx Payment System
Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts